Literature DB >> 7502488

Improved competitive enzyme immunoassay for the diagnosis of bovine brucellosis.

K H Nielsen1, L Kelly, D Gall, P Nicoletti, W Kelly.   

Abstract

A modification of the competitive enzyme-linked immunosorbent assay (C-ELISA) for differentiating the antibody response of cattle vaccinated with Brucella abortus strain 19 and B. abortus infected cattle is described. This assay utilizes lipopolysaccharide as the antigen, immobilized on a polystyrene matrix, and a monoclonal antibody (M84) with specificity for an epitope of the O-polysaccharide. A goat anti-mouse IgG antibody-enzyme conjugate is used for detection. The specificity of the modified assay was 99.7% when 1446 sera from brucellosis free herds were tested and it correctly identified 636 sera from B. abortus infected cattle as positive, using a cut-off of 30% inhibition, for a sensitivity estimate of 100%. No reactions were noted among 261 sera from vaccinated cattle. However, in testing 1147 sera that gave positive reactions in the buffered plate antigen test, the indirect ELISA, the complement fixation test or a combination of these tests from the serum bank, 31 gave positive reactions. Twenty-seven of the 31 sera originated from recently vaccinated cattle. The overall specificity for sera from vaccinated cattle was 97.3%. Because of the sensitivity and specificity of this procedure and its ease of performance, it would be a reasonable alternative as a single assay for serological diagnosis of brucellosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7502488     DOI: 10.1016/0165-2427(94)05361-u

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  33 in total

1.  Evaluation of a competitive ELISA for the diagnosis of bovine brucellosis.

Authors:  F A Uzal; A E Carrasco; K H Nielsen
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  A lysozyme-like protein in Brucella abortus is involved in the early stages of intracellular replication.

Authors:  Mariela G Del Giudice; Juan E Ugalde; Cecilia Czibener
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

3.  Brucellosis among smallholder cattle farmers in Zambia: public health significance.

Authors:  John Bwalya Muma; Girja Shankar Pandey; Musso Munyeme; Chisoni Mumba; Ethel Mkandawire; Henry Mwelwa Chimana
Journal:  Trop Anim Health Prod       Date:  2011-09-27       Impact factor: 1.559

4.  Identification of a type IV secretion substrate of Brucella abortus that participates in the early stages of intracellular survival.

Authors:  Peter H Döhmer; Ezequiel Valguarnera; Cecilia Czibener; Juan E Ugalde
Journal:  Cell Microbiol       Date:  2013-11-03       Impact factor: 3.715

5.  Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.

Authors:  G Briones; N Iñón de Iannino; M Roset; A Vigliocco; P S Paulo; R A Ugalde
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Development and comparative evaluation of a competitive ELISA with rose bengal test and a commercial indirect ELISA for serological diagnosis of brucellosis.

Authors:  Tadepalli Mythili; Lingala Rajendra; Trangadia Bhavesh; Dorairajan Thiagarajan; Villuppanoor Alwar Srinivasan
Journal:  Indian J Microbiol       Date:  2011-02-02       Impact factor: 2.461

7.  Identification of a unique gene cluster of Brucella spp. that mediates adhesion to host cells.

Authors:  Cecilia Czibener; Juan Esteban Ugalde
Journal:  Microbes Infect       Date:  2011-08-31       Impact factor: 2.700

8.  A Bacterial Glycoengineered Antigen for Improved Serodiagnosis of Porcine Brucellosis.

Authors:  María E Cortina; Rodrigo E Balzano; Diego A Rey Serantes; Ana J Caillava; Sebastián Elena; A C Ferreira; Ana M Nicola; Juan E Ugalde; Diego J Comerci; Andrés E Ciocchini
Journal:  J Clin Microbiol       Date:  2016-03-16       Impact factor: 5.948

9.  Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine.

Authors:  Juan Esteban Ugalde; Diego José Comerci; M Susana Leguizamón; Rodolfo Augusto Ugalde
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Comparison of a flow assay for brucellosis antibodies with the reference cELISA test in West African Bos indicus.

Authors:  Barend M deC Bronsvoort; Bronwyn Koterwas; Fiona Land; Ian G Handel; James Tucker; Kenton L Morgan; Vincent N Tanya; Theresia H Abdoel; Henk L Smits
Journal:  PLoS One       Date:  2009-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.